← Leaderboards
Mark G Kris
Sloan-Kettering Institute For Cancer Res
$4,094,204
Attributed
$5,351,847
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$31,670,521 · 6
By mechanism
P01$28,046,564 · 4
T32$1,891,221 · 1
R01$1,732,736 · 1
Top collaborators
- Marc Ladanyi15 shared
- Jedd D. Wolchok4 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Marc Ladanyi$28,443,479
- Joan Massague$31,163,003
- Peter B. Bach$2,957,726
- Steven A Leibel$631,133
- George J. Bosl$8,065,724
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMalignant Neoplasm Of LungProgramsGrantEnsureAdvisory CommitteesResearch Project GrantsLungResearch PersonnelPersonsCommunicationAmericasLung CarcinomaCessation Of LifeMedicinePreventNeoplasm MetastasisLinkCaringInvestigationLaboratoriesEventDrug SensitivityPrincipal Investigator
Grant awards (35)
Targets for Therapy for Carcinomas of the Lung$1,671,655
P01 · FY2022 · CA · contact PI
Administrative Core$143,875
P01 · FY2022 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,705,771
P01 · FY2021 · CA · contact PI
Administrative Core$146,812
P01 · FY2021 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,705,771
P01 · FY2020 · CA · contact PI
Administrative Core$146,812
P01 · FY2020 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,654,596
P01 · FY2019 · CA · contact PI
Administrative Core$159,637
P01 · FY2019 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,725,669
P01 · FY2018 · CA · contact PI
Administrative Core$164,575
P01 · FY2018 · CA · contact PI
Investigational Cancer Therapeutics Training Program$494,599
T32 · FY2017 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,736,914
P01 · FY2016 · CA · contact PI
Investigational Cancer Therapeutics Training Program$442,811
T32 · FY2016 · CA · contact PI
Administration Core$127,217
P01 · FY2016 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,736,914
P01 · FY2015 · CA · contact PI
Investigational Cancer Therapeutics Training Program$524,686
T32 · FY2015 · CA · contact PI
Administration Core$127,217
P01 · FY2015 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,684,807
P01 · FY2014 · CA · contact PI
Investigational Cancer Therapeutics Training Program$429,125
T32 · FY2014 · CA · contact PI
Administration Core$119,774
P01 · FY2014 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,632,700
P01 · FY2013 · CA · contact PI
Administration$119,583
P01 · FY2013 · CA · contact PI
Targets for Therapy for Carcinomas of the Lung$1,777,814
P01 · FY2012 · CA · contact PI
Administration$130,274
P01 · FY2012 · CA · contact PI
New Targets for Therapy for Adenocarcinoma of the Lung$1,813,235
P01 · FY2011 · CA · contact PI
New Targets for Therapy for Adenocarcinoma of the Lung$1,885,662
P01 · FY2010 · CA · contact PI
New Targets for Therapy for Adenocarcinoma of the Lung$1,915,760
P01 · FY2009 · CA · contact PI
New Targets for Therapy for Adenocarcinoma of the Lung$1,818,836
P01 · FY2008 · CA · contact PI
Methylated Genes as Serum Biomarkers for Lung Cancer$351,703
R01 · FY2008 · CA · contact PI
New Targets for Therapy for Adenocarcinoma of the Lung$1,852,570
P01 · FY2007 · CA · contact PI
Methylated Genes as Serum Biomarkers for Lung Cancer$350,906
R01 · FY2007 · CA · contact PI
Administration and Analysis$342,114
P01 · FY2007 · CA · contact PI
Methylated Genes as Serum Biomarkers for Lung Cancer$339,933
R01 · FY2006 · CA · contact PI
Methylated Genes as Serum Biomarkers for Lung Cancer$340,498
R01 · FY2005 · CA
Methylated Genes as Serum Biomarkers for Lung Cancer$349,696
R01 · FY2004 · CA